Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

The Lancet Respiratory Medicine

Volumn 5, Issue 8, 2017, Pages 619-626

  Han, MeiLan K ^a,u   Quibrera, Pedro M ^b   Carretta, Elizabeth E ^b,u   Barr, R Graham ^c,u   Bleecker, Eugene R ^d,u   Bowler, Russell P ^e,u   Cooper, Christopher B ^f,u   Comellas, Alejandro ^g,u   Couper, David J ^b,u   Curtis, Jeffrey L ^a,h,u   Criner, Gerard ⁱ   Dransfield, Mark T ^j,u   Hansel, Nadia N ^k,u   Hoffman, Eric A ^l,u   Kanner, Richard E ^m,u   Krishnan, Jerry A ^n,u   Martinez, Carlos H ^a   Pirozzi, Cheryl B ^m   O'Neal, Wanda K ^b,u   Rennard, Stephen ^o,p   Tashkin, Donald P ^f,u   Wedzicha, Jadwiga A ^q   Woodruff, Prescott ^r   Paine, Robert ^m,s,u   Martinez, Fernando J ^t,u   Alexis, Neil E ^u   Anderson, Wayne H ^u   Boucher, Richard C ^u   Christenson, Stephanie A ^u   Criner, Gerard J ^u   Crystal, Ronald G ^u   Doerschuk, Claire M ^u   Freeman, Christine M ^u   Hastie, Annette T ^u   Kaner, Robert J ^u   Kleerup, Eric C ^u   LaVange, Lisa M ^u   Lazarus, Stephen C ^u   Meyers, Deborah A ^u   Newell, John D ^u   Oelsner, Elizabeth C ^u   Putcha, Nirupama ^u   Rennard, Stephen I ^u   Scholand, Mary Beth ^u   Wells, J Michael ^u   Wise, Robert A ^u   Woodruff, Prescott G ^u   more..

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c Columbia University ^*  (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

ⁱ TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF IOWA   (United States)

^m UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^o UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^p ASTRAZENECA   (United Kingdom)

^q IMPERIAL COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s VETERANS AFFAIRS MEDICAL CENTER   (United States)

^t WEILL CORNELL MEDICAL COLLEGE   (United States)

^u NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 8; BIOLOGICAL MARKER; IL8 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL AIRWAY DISEASE; SPIROMETRY; UNIVERSITY HOSPITAL; BLOOD; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FORCED EXPIRATORY VOLUME; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-15; INTERLEUKIN-8; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85021352805     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30207-2     Document Type: Article

References (19)

1. Jones, PW, St. George's respiratory questionnaire: MCID. COPD 2 (2005), 75–79.
2. Seemungal, TA, Donaldson, GC, Paul, EA, Bestall, JC, Jeffries, DJ, Wedzicha, JA, Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998), 1418–1422.
3. Donaldson, GC, Seemungal, TA, Bhowmik, A, Wedzicha, JA, Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002), 847–852.
4. Bhatt, SP, Soler, X, Wang, X, et al. Association between functional small airways disease and FEV1 decline in COPD. Am J Respir Crit Care Med 194 (2016), 178–184.
5. McGhan, R, Radcliff, T, Fish, R, Sutherland, ER, Welsh, C, Make, B, Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132 (2007), 1748–1755.
6. Buist, AS, Vollmer, WM, McBurnie, MA, Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 12 (2008), 703–708.
7. Pavord, ID, Jones, PW, Burgel, PR, Rabe, KF, Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 11 (2016), 21–30.
8. Hurst, JR, Vestbo, J, Anzueto, A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363 (2010), 1128–1138.
9. Vestbo, J, Hurd, SS, Agustí, AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187 (2013), 347–365.
10. Couper, D, LaVange, LM, Han, M, et al. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 69 (2014), 491–494.
11. Hankinson, JL, Odencrantz, JR, Fedan, KB, Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1999), 179–187.
12. Sturrock, A, Seedahmed, E, Mir-Kasimov, M, Boltax, J, McManus, ML, Paine, R 3rd, GM-CSF provides autocrine protection for murine alveolar epithelial cells from oxidant-induced mitochondrial injury. Am J Physiol Lung Cell Mol Physiol 302 (2012), L343–L351.
13. Sieren, JP, Newell, JD Jr, Barr, RG, et al. SPIROMICS protocol for multicenter quantitative computed tomography to phenotype the lungs. Am J Respir Crit Care Med 194 (2016), 794–806.
14. Patel, BD, Coxson, HO, Pillai, SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178 (2008), 500–505.
15. Galban, CJ, Han, MK, Boes, JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 18 (2012), 1711–1715.
16. Jones, PW, Harding, G, Berry, P, Wiklund, I, Chen, WH, Kline Leidy, N, Development and first validation of the COPD assessment test. Eur Respir J 34 (2009), 648–654.
17. Donaldson, GC, Mullerova, H, Locantore, N, et al. Factors associated with change in exacerbation frequency in COPD. Respir Res, 14, 2013, 79.
18. Brusse-Keizer, M, van der Palen, J, van der Valk, P, Hendrix, R, Kerstjens, H, Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease. Clin Respir J 5 (2011), 227–234.
19. Han, MK, Kazerooni, EA, Lynch, DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology 261 (2011), 274–282.